Target intelligence / Profile preview

G protein-coupled receptor 137C (GPR137C)

Target
GPR137C
Molecular classification
G protein-coupled receptor, Integral membrane protein, 7-transmembrane receptor superfamily, Orphan GPCR
01

Overview

G protein-coupled receptor 137C (GPR137C) is a predicted integral membrane receptor belonging to the large family of seven-transmembrane G protein-coupled receptors. Orthologs are present in humans and model organisms (e.g., zebrafish). GPR137C is localized to the lysosomal membrane and may play a role in positive regulation of TORC1/mTOR signaling, but its precise endogenous ligand, cellular function in humans, and disease relevance remain poorly characterized. It is currently considered an orphan receptor with no confirmed ligands or drug interactions, and is not yet established as a diagnostic or therapeutic target. Like other GPCRs, it likely functions in membrane signal transduction and could in the future be relevant for drug development once its pharmacology and biology are clarified.

Other names
Integral membrane protein GPR137CTM7SF1L2DKFZp762F0713Transmembrane 7 superfamily member 1-like 2 proteinG protein-coupled receptor TM7SF1L2
02

Mechanism of action

Unknown; as no drugs or endogenous ligands have been confirmed. By analogy to other GPCRs: if ligands are found, likely operates via downstream G protein signaling with potential second messenger effects (cAMP, IP3, calcium, etc.).

03

Biological functions

Predicted signal transductionPositive regulation of TORC1 signaling (mTOR pathway)Likely involved in cellular localization to lysosomal membranesLikely involved in membrane signaling
04

Disease associations

Evidence for direct disease associations (e.g., cancer, inflammation) is currently lacking for GPR137C itselfGPCRs generally have extensive roles in many diseases, but GPR137C is currently not well described as a disease marker or cause
05

Safety considerations

No known safety dataTarget validation challengesRisk of off-target effects seen with other GPCR modulationGeneral safety concerns for GPCR-targeting drugs include broad tissue distribution and pleiotropic effects, but specifics for GPR137C are not known

Beyond the preview

Go deeper on G protein-coupled receptor 137C (GPR137C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor 137C (GPR137C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call